Today we announced exciting new data from our Phase 1b/2 study of #palazestrant in combination with #ribociclib in ER+/HER2- #MetastaticBreastCancer, which will be presented at #ESMO25. For those in Berlin, we invite you to join us at our poster session on Monday! Follow the link for the full press release, including data and presentation details: http://bit.ly/4hjpvsj
About us
Olema Oncology is a cancer medicines company dedicated to impacting breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a differentiated oral medicine known as a complete estrogen receptor antagonist (CERAN) initially in development for metastatic breast cancer. Our pipeline also includes OP-3136, a potent, selective oral inhibitor of the KAT6 pathway. At Olema, we are building a focused team committed to our mission with intention and clarity. Working alongside a talented, passionate group of leaders and advisors, we strive to create better medicines that aim to help patients feel better, longer. For more information, visit us at www.olema.com. Important Notice: Fraudulent Recruiting Activities We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com; our careers page is olema.com/careers; our LinkedIn page is linkedin.com/company/olema-oncology. Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.
- Website
-
http://olema.com
External link for Olema Oncology
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Francisco, California
- Type
- Public Company
- Founded
- 2007
- Specialties
- pharmaceuticals, biotechnology, drug development, oncology, breast cancer, nuclear receptors, and small molecules
Locations
-
Primary
780 Brannan St
San Francisco, California 94103, US
-
101 Rogers St
3B
Cambridge, Massachusetts 02142, US
Employees at Olema Oncology
-
Maribel Teixeira
-
David Kwasha
Chief Executive Officer at AHAA! (Avril Henry and Associates) Pty Ltd
-
Shawnte Mitchell
Global C-Suite Life Science/Biotech Executive | Board Member | Strategy | Transactions/Licensing | Regulatory | Risk Management | Compliance
-
Krishna Singh
Helping pharmaceutical company to navigate clinical trials with GxP quality, regulatory compliance and inspection readiness.
Updates
-
Hello, Berlin! #TeamOlema is on the ground at #ESMO25 and ready for a weekend packed with collaboration, scientific exchange, and groundbreaking discoveries. We look forward to presenting our updated #palazestrant plus #ribociclib data and are proud to be a part of the community shaping the future of cancer care.
-
-
We’re developing more than just cancer therapies at Olema — we’re building a culture that reaches for what’s beyond. Here, every recognition is a reflection of the collaboration, dedication, and passion each team member brings to our mission. We’re creating a workplace that thrives on impact, innovation, and the shared belief that what we do today sets the stage for what’s next in oncology. For the second year in a row, we are #GPTWCertified — a milestone wouldn’t be possible without every incredible member of #TeamOlema. Thank you all for making Olema a place where people, purpose, and possibility come together! #CertificationNationDay https://bit.ly/46W2NmK
-
-
Join us at the Susan G. Komen Boston #MoreThanPinkWalk this weekend in Cambridge! We’re proud to sponsor this powerful event that brings the community together in the fight against #BreastCancer. Whether you walk, donate, or cheer from afar, your support helps make a difference. Learn more here: https://bit.ly/48vf1nn #BreastCancerAwarenessMonth
-
-
#MetastaticBreastCancer is the most advanced form of breast cancer—and it impacts far too many lives. On #MetastaticBreastCancerAwarenessDay, we stand with those living with this disease and those who support them every day. #TeamOlema is driven by the possibility of what’s beyond—because progress means more time, more options, and more hope.
-
The Susan G. Komen Bay Area #MoreThanPinkWalk was an incredible morning filled with purpose, inspiration, and impact! We’re proud to stand alongside so many who are raising awareness, raising funds, and supporting those affected by #BreastCancer. Our San Francisco colleagues raised more than $13,000 for Susan G. Komen, which placed us amongst the top three fundraising teams for the region! Way to go, #TeamOlema! Check out the full San Francisco leaderboard here: https://bit.ly/47dMVMl Coming up next weekend: the More Than Pink Walk in Boston!
-
This #BreastCancerAwarenessMonth, we’re proud to highlight the voices of our team who are driving progress in science and care. Hear from Yolande Du Toit, MD, VP of Medical Affairs, as she shares her perspective on the impact of every advance in #BreastCancer treatment—reminding us why #TeamOlema is working for what’s beyond.
-
-
#BreastCancerAwarenessMonth continues to inspire our commitment to advancing care for those living with #BreastCancer and beyond. This year, we’re honored to sponsor Susan G. Komen’s Bay Area #MoreThanPinkWalk — a cause that resonates deeply with our mission. Join us in driving meaningful progress. We'll see you on October 5th! Together, we can create a brighter future. Learn more here: https://bit.ly/42LkVxd
-
-
We’re looking for an experienced, senior leader to join #TeamOlema as Vice President of Commercial Strategy and Operations—Olema’s first commercial hire. This is a unique opportunity to build what doesn’t yet exist: designing our commercial foundation and shaping the strategy that will define Olema’s future. If you’re ready to guide a clinical-stage biotech through its pivotal transition to a launch-ready organization—and directly impact how patients access innovative medicines—this role is for you. Learn more and apply: https://bit.ly/4o5mRbT #BiotechCareers #NowHiring
-
-
During #BreastCancerAwarenessMonth, we’re reminded of why we push boundaries to think beyond what we know today about #BreastCancer. #TeamOlema is proud to take fearless strides - every day - to accelerate scientific and clinical advances for better outcomes for people living with this devastating disease. At Olema, we work for our patients, for our people, and for what’s beyond.
-